annual current liabilities:
$16.75B+$1.47B(+9.61%)Summary
- As of today (June 1, 2025), TAK annual total current liabilities is $16.75 billion, with the most recent change of +$1.47 billion (+9.61%) on March 1, 2025.
- During the last 3 years, TAK annual current liabilities has fallen by -$828.89 million (-4.71%).
- TAK annual current liabilities is now -27.25% below its all-time high of $23.03 billion, reached on March 31, 2019.
Performance
TAK Current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly current liabilities:
$16.75B+$3.39B(+25.38%)Summary
- As of today (June 1, 2025), TAK quarterly total current liabilities is $16.75 billion, with the most recent change of +$3.39 billion (+25.38%) on March 1, 2025.
- Over the past year, TAK quarterly current liabilities has increased by +$1.47 billion (+9.61%).
- TAK quarterly current liabilities is now -27.25% below its all-time high of $23.03 billion, reached on March 31, 2019.
Performance
TAK quarterly current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Current liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
TAK Current liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +9.6% | +9.6% |
| 3 y3 years | -4.7% | -4.7% |
| 5 y5 years | -16.8% | -16.8% |
TAK Current liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -10.1% | +9.6% | -10.1% | +25.4% |
| 5 y | 5-year | -16.8% | +9.6% | -16.8% | +25.4% |
| alltime | all time | -27.3% | +511.2% | -27.3% | +302.8% |
TAK Current liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | $16.75B(+9.6%) | $16.75B(+25.4%) |
| Dec 2024 | - | $13.36B(-20.1%) |
| Sep 2024 | - | $16.72B(+9.1%) |
| Jun 2024 | - | $15.32B(+0.2%) |
| Mar 2024 | $15.28B(-18.0%) | $15.28B(-5.6%) |
| Dec 2023 | - | $16.18B(+2.1%) |
| Sep 2023 | - | $15.85B(-8.3%) |
| Jun 2023 | - | $17.28B(-7.2%) |
| Mar 2023 | $18.63B(+6.0%) | $18.63B(+9.2%) |
| Dec 2022 | - | $17.06B(+3.0%) |
| Sep 2022 | - | $16.56B(+4.4%) |
| Jun 2022 | - | $15.86B(-9.8%) |
| Mar 2022 | $17.58B(+9.4%) | $17.58B(+11.8%) |
| Dec 2021 | - | $15.72B(-8.3%) |
| Sep 2021 | - | $17.14B(+11.0%) |
| Jun 2021 | - | $15.44B(-3.9%) |
| Mar 2021 | $16.07B(-20.2%) | $16.07B(-8.2%) |
| Dec 2020 | - | $17.50B(+8.2%) |
| Sep 2020 | - | $16.18B(-14.3%) |
| Jun 2020 | - | $18.88B(-6.2%) |
| Mar 2020 | $20.13B(-12.6%) | $20.13B(+3.1%) |
| Dec 2019 | - | $19.54B(+29.0%) |
| Sep 2019 | - | $15.14B(-18.6%) |
| Jun 2019 | - | $18.60B(-19.2%) |
| Mar 2019 | $23.03B(+231.8%) | $23.03B(+191.5%) |
| Dec 2018 | - | $7.90B(+6.4%) |
| Sep 2018 | - | $7.43B(+11.9%) |
| Jun 2018 | - | $6.64B(-4.4%) |
| Mar 2018 | $6.94B(-43.2%) | $6.94B(-10.9%) |
| Dec 2017 | - | $7.79B(+4.5%) |
| Sep 2017 | - | $7.46B(-11.1%) |
| Jun 2017 | - | $8.39B(-31.4%) |
| Mar 2017 | $12.22B(+60.2%) | $12.22B(+48.4%) |
| Dec 2016 | - | $8.24B(+3.1%) |
| Sep 2016 | - | $7.99B(-0.2%) |
| Jun 2016 | - | $8.00B(+4.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2016 | $7.63B(-10.0%) | $7.63B(-9.1%) |
| Dec 2015 | - | $8.39B(+2.1%) |
| Sep 2015 | - | $8.22B(-0.2%) |
| Jun 2015 | - | $8.24B(-2.7%) |
| Mar 2015 | $8.47B(+8.6%) | $8.47B(+20.8%) |
| Dec 2014 | - | $7.01B(-1.5%) |
| Sep 2014 | - | $7.12B(-2.5%) |
| Jun 2014 | - | $7.30B(-6.4%) |
| Mar 2014 | $7.80B(+15.9%) | $7.80B(+40.9%) |
| Dec 2013 | - | $5.54B(-0.9%) |
| Sep 2013 | - | $5.59B(+1.3%) |
| Jun 2013 | - | $5.52B(-18.0%) |
| Mar 2013 | $6.73B(-27.0%) | $6.73B(+1.0%) |
| Dec 2012 | - | $6.66B(+5.9%) |
| Sep 2012 | - | $6.29B(-31.3%) |
| Jun 2012 | - | $9.15B(-0.8%) |
| Mar 2012 | $9.22B(+75.8%) | $9.22B(-30.2%) |
| Dec 2011 | - | $13.22B(-0.3%) |
| Sep 2011 | - | $13.25B(+174.7%) |
| Jun 2011 | - | $4.83B(-8.1%) |
| Mar 2011 | $5.25B(+14.6%) | $5.25B(+14.0%) |
| Dec 2010 | - | $4.60B(+2.7%) |
| Sep 2010 | - | $4.48B(+7.7%) |
| Jun 2010 | - | $4.16B(-9.2%) |
| Mar 2010 | $4.58B(-3.9%) | $4.58B(-0.1%) |
| Dec 2009 | - | $4.58B(-4.1%) |
| Sep 2009 | - | $4.78B(+0.3%) |
| Mar 2009 | $4.77B(+11.1%) | $4.77B(+5.6%) |
| Dec 2008 | - | $4.52B |
| Mar 2008 | $4.29B(+14.4%) | - |
| Mar 2007 | $3.75B(-9.5%) | - |
| Mar 2006 | $4.15B(+21.6%) | - |
| Mar 2005 | $3.41B(-4.1%) | - |
| Mar 2004 | $3.56B(+21.7%) | - |
| Mar 2003 | $2.92B(+4.4%) | - |
| Mar 2002 | $2.80B(+2.1%) | - |
| Mar 2001 | $2.74B | - |
FAQ
- What is Takeda Pharmaceutical Company Limited annual total current liabilities?
- What is the all time high annual current liabilities for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited annual current liabilities year-on-year change?
- What is Takeda Pharmaceutical Company Limited quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited quarterly current liabilities year-on-year change?
What is Takeda Pharmaceutical Company Limited annual total current liabilities?
The current annual current liabilities of TAK is $16.75B
What is the all time high annual current liabilities for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high annual total current liabilities is $23.03B
What is Takeda Pharmaceutical Company Limited annual current liabilities year-on-year change?
Over the past year, TAK annual total current liabilities has changed by +$1.47B (+9.61%)
What is Takeda Pharmaceutical Company Limited quarterly total current liabilities?
The current quarterly current liabilities of TAK is $16.75B
What is the all time high quarterly current liabilities for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high quarterly total current liabilities is $23.03B
What is Takeda Pharmaceutical Company Limited quarterly current liabilities year-on-year change?
Over the past year, TAK quarterly total current liabilities has changed by +$1.47B (+9.61%)